Entries of Fante, Matthias on the publication server

Denk, Alexander , Mittermaier, Cornelia, Weber, Daniela, Fante, Matthias, Güneş, Sibel, Edinger, Matthias, Herr, Wolfgang and Wolff, Daniel (2024) Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis. Annals of Hematology 103, pp. 3755-3764.

Denk, Alexander , Edinger, Matthias, Weber, Daniela, Holler, Ernst, Fante, Matthias, Meedt, Elisabeth, Güneş, Sibel, Poeck, Hendrik, Mittermaier, Cornelia, Herr, Wolfgang and Wolff, Daniel (2024) Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis. Annals of Hematology 103, pp. 3071-3081.

Derigs, Patrick, Bethge, Wolfgang A., Krämer, Isabelle, Holtick, Udo, von Tresckow, Bastian, Ayuk, Francis, Penack, Olaf, Vucinic, Vladan, von Bonin, Malte, Baldus, Claudia, Mougiakakos, Dimitrios, Wulf, Gerald, Schnetzke, Ulf, Stelljes, Matthias, Fante, Matthias, Schroers, Roland, Kroeger, Nicolaus and Dreger, Peter (2023) Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis. Transplantation and Cellular Therapy 29 (12), pp. 750-756. Fulltext not available.

Kayser, Sabine, Sartor, Chiara, Luskin, Marlise R. , Webster, Jonathan, Giglio, Fabio, Panitz, Nydia, Brunner, Andrew M., Fante, Matthias, Lutz, Christoph, Wolff, Daniel, Ho, Anthony D., Levis, Mark J., Schlenk, Richard F. and Papayannidis, Cristina (2022) Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin. Haematologica 107 (9), pp. 2064-2071. Fulltext not available.

Wertheimer, Tobias , Dohse, Marius, Afram, Gabriel, Weber, Daniela, Heidenreich, Martin, Holler, Barbara, Kattner, Anna-Sophia, Neubauer, Andreas, Mielke, Stephan, Ljungman, Per, Holler, Ernst, Herr, Wolfgang, Edinger, Matthias, Martínez, Antonio Pérez, Fante, Matthias and Wolff, Daniel (2021) Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis. Annals of Hematology 100, pp. 779-787.

Renner, Kathrin , Bruss, Christina, Schnell, Annette, Koehl, Gudrun, Becker, Holger M., Fante, Matthias, Menevse, Ayse-Nur, Kauer, Nathalie, Blazquez, Raquel, Hacker, Lisa, Decking, Sonja-Maria, Bohn, Toszka, Faerber, Stephanie, Evert, Katja, Aigle, Lisa, Amslinger, Sabine, Landa, Maria, Krijgsman, Oscar, Rozeman, Elisa A., Brummer, Christina, Siska, Peter J., Singer, Katrin, Pektor, Stefanie, Miederer, Matthias, Peter, Katrin, Gottfried, Eva, Herr, Wolfgang, Marchiq, Ibtisam, Pouyssegur, Jacques, Roush, William R., Ong, SuFey, Warren, Sarah, Pukrop, Tobias , Beckhove, Philipp , Lang, Sven A., Bopp, Tobias, Blank, Christian U., Cleveland, John L., Oefner, Peter J., Dettmer, Katja , Selby, Mark and Kreutz, Marina (2019) Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy. Cell Reports 29 (1), 135-150.e9.

Renner, Kathrin, Seilbeck, Anton, Kauer, Nathalie, Ugele, Ines, Siska, Peter J., Brummer, Christina, Bruss, Christina, Decking, Sonja-Maria, Fante, Matthias, Schmidt, Astrid, Hammon, Kathrin, Singer, Katrin, Klobuch, Sebastian, Thomas, Simone , Gottfried, Eva, Peter, Katrin and Kreutz, Marina (2018) Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Frontiers in Pharmacology 9 (1258), pp. 1-13.

Fante, Matthias (2018) Impact of an anti-metabolic therapy on leukemic and non-malignant T cells. PhD, Universität Regensburg.

Renner, Kathrin, Geiselhöringer, Anna-Lena, Fante, Matthias, Bruss, Christina, Färber, Stephanie, Schönhammer, Gabriele, Peter, Katrin, Singer, Katrin, Andreesen, Reinhard, Hoffmann, Petra, Oefner, Peter J. , Herr, Wolfgang and Kreutz, Marina (2015) Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions. Eur J Immunol 45 (9), pp. 2504-2516. Fulltext not available.